Deficits in inhibition and flexibility are associated with the APOE-E4 allele in nondemented older adults

Journal of Clinical and Experimental Neuropsychology

Volumn 27, Issue 8, 2005, Pages 943-952

  Wetter, Spencer R ^a   Delis, Dean C ^a,b   Houston, Wes S ^a   Jacobson, Mark W ^b   Lansing, Amy ^b   Cobell, Krystal ^a   Salmon, David P ^b   Bondi, Mark W ^a,b  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; DISEASE ASSOCIATION; ERROR; FEMALE; FUNCTIONAL DISEASE; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; INHIBITION (PSYCHOLOGY); MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SENESCENCE; TASK PERFORMANCE; VARIANCE;

AGED; ALLELES; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; COGNITION; COLOR PERCEPTION; FEMALE; HUMANS; INHIBITION (PSYCHOLOGY); MALE; MENTAL DISORDERS; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; PSYCHOMOTOR PERFORMANCE;

EID: 27344432678     PISSN: 13803395     EISSN: None     Source Type: Journal    
DOI: 10.1080/13803390490919001     Document Type: Article

References (39)

1. Albert, M.S., Moss, M.B., Tanzi, R., & Jones, K. (2001). Preclinical prediction on AD using neuropsychological tests. JINS, 7, 631-639.
2. Arikuni, T., Sake, H., & Murata, A. (1994). Ipsilateral connections of the anterior cingulate cortex with the frontal and medial temporal cortices in the macaque monkey. Neuroscience Research, 21, 19-39.
3. Bondi, M.W., Salmon, D.P., Galasko, D., Thomas, R.G., & Thai, L.J. (1999). Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. Psychology & Aging, 14, 295-303.
4. Bondi, M.W., Salmon, D.P., Monsch, A.U., Galasko, D., Butters, N., & Klauber, M.R. et al. (1995). Episodic memory changes are associated with the APOE-e4 allele in nondemented older adults. Neurology, 45, 2203-2206.
5. Bondi, M.W., Serody, A.B., Chan, A.S., Eberson-Shumate, S.C., Delis, D.C., Hansen, L.A., & Salmon, D.P. (2002). Cognitive and neuropathologic correlates of Stroop color-word test performance in Alzheimer's disease. Neuropsychology, 16, 335-343.
6. Chen, P., Ratcliff, G., Phil, D., Belle, S.H., Cauley, J.A., DeKosky, S.T., & Ganguli, M. (2000). Cognitive tests that best discriminate between presymptomatic AD and those who remain non-demented. Neurology, 55, 1847-1853.
7. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, G.L., & Pericak-Vance, M.A. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921-923.
8. de Leeuw, F.E., Richard, F., de Groot, J.C., van Duijn, C.M., Hofman, A., Van Gijn, J., & Breteler, M.M. (2004). Interaction between hypertension, apoE, and cerebral white matter lesions. Stroke, 35, 1057-1060.
9. Delis, D.C., Kaplan, E., & Kramer, J.H. (2001a). Delis-Kaplan Executive Function System (D-KEFS). San Antonio: The Psychological Corporation.
10. Delis, D.C., Kaplan, E., & Kramer, J.H. (2001b). The Delis-Kaplan Executive Function System-technical manual. New York: The Psychological Corporation.
11. Elias, M., Beiser, A., Wolf, P., Au, R., White, R., & D'Agostino, R. (2000). The preclinical phase of Alzheimer disease: A 22-year prospective study of the Framingham cohort. Archives of Neurology, 57, 808-813.
12. Etiene, D., Kraft, J., Ganju, N., Gomez-Isla, T., Gemelli, B., Hyman, B.T., Hedley-Whyte, E.T., Wands, J.R., & De La Monte, S.M. (1998). Cerebrovascular pathology contributes to the heterogeneity of Alzheimer's disease. Journal of Alzheimer's Disease, 1, 119-134.
13. Fisher, L.M., Freed, D.M., & Corkin, S. (1990). Stroop Color-Word Test performance in patients with Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology, 17, 654-667.
14. Houston, W.S., Lansing, A., Delis, D.C., Jacobson, M.W., Cobell, K.R., & Bondi, M.W. (submitted). Executive function asymmetries in elderly adults genetically at-risk for Alzheimer's disease: Verbal versus design fluency. Journal of the International Neuropsychological Society.
15. Jacobs, D.M., Sano, M., Dooneief, G., Marder, K., Bell, K., & Stern, Y. (1995). Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology, 5, 957-962.
16. Jacobson, M.W., Delis, D.C., Bondi, M.W., & Salmon, D.P. (2002). Do neuropsychological tests detect preclinical Alzheimer's disease: Individual-test versus cognitive-discrepancy score analyses. Neuropsychology, 16, 132-139.
17. Johnson, K.A., Jones, K., Holman, B.L., Becker, J.A, Spiers, P.A., Satlin, A., & Albert, M.S. (1998). Preclinical prediction of Alzheimer's disease using SPECT. Neurology, 50, 1563-71.
18. Johnstone, B., Hogg, J.R., Schopp, L.H., Kapila, C., & Edwards, S. (2002). Neuropsychological deficit profiles in senile dementia of the Alzheimer's type. Archives of Clinical Neuropsychology, 17, 273-282.
19. Killiany, R.J., Gomez-Isla, T., Moss, M., Kikinis, R., Sandor, T., Jolesz, F., Tanzi, R., Jones, K., Hyman, B.T., & Albert, M.S. (2000). Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Annals of Neurology, 47, 430-9.
20. Koss, E., Ober, B., Delis, D., & Friedland, R. (1984). The Stroop Color-Word Test: Indicator of dementia severity. International Journal of Neuroscience, 24, 150-157.
21. Linn, R., Wolf, P., Bachman, D., & Knoefel, J. (1995). The "preclinical phase" of probable Alzheimer's disease: A 13-year prospective study of the Framingham cohort. Archives of Neurology, 52, 485-490.
22. Macleod, C.M. (1991). Half a century of research on the Stroop effect: An integrative review. Psychological Bulletin, 109, 163-203.
23. Mattis, S. (1973). Dementia Rating Scale: Professional manual. Odessa, FL: Psychological Assessment Resources.
24. Monsch, A., Bondi, M., Salmon, D., & Butters, N. (1995). Clinical validity of the Mattis Dementia Rating Scale in detecting dementia of the Alzheimer type: A double cross-validation and application to a community-dwelling sample. Archives of Neurology, 52, 899-904.
25. Parasuraman, R., Greenwood, P.M., & Sunderland, T. (2002). The apolipoprotein E gene, attention, and brain function. Neuropsychology, 16, 254-274.
26. Pericak-Vance, M.A., Bebout, J.L., & Gaskell, P.C. et al. (1991). Linkage studies in familial Alzheimer disease: Evidence for chromosome 19 linkage. American Journal of Human Genetics, 48, 1034-1050.
27. Petrides, M., & Milner, B. (1982). Deficits in subject-ordered tasks after frontal and temporal lobe lesions in man. Neuropsychologia, 20, 249-262.
28. Reiman, E.M., Caselli, R.J., Chen, K., Alexander, G.E., Bandy, D., & Frost, J. (2001). Declining brain activity in cognitively normal apolipoprotein E e4 heterozygotes: A foundation for using postiron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proceedings of the National Academy of Sciences, 98, 3334-3339.
29. Reitan, R. (1955). The relation of the Trailmaking Test to organic brain damage. Journal of Consultation Psychology, 19, 393-394.
30. Rosen, V.M., Bergeson, J.L., Putnam, K., Harwell, A., & Sunderland, T. (2002). Working memory in apolipoprotein E: What's the connection?. Neuropsychologia, 40, 2226-2233.
31. Saunders, A.M., Strittmatter, W.J., Schmechel, D., St. George-Hyslop, P.H., Pericak-Vance, M.A., Joo, S.H., Rosi, B.L., Gusella, J.F., Crapper-MacLachlan, D.R., Alberts, M.J., Hulette, C., Crain, B., Goldbager, D., & Roses, A.D. (1993). Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology, 43, 1467-1472.
32. Slooter, A.J.C., Cruts, M., Hofman, A., Koudstaal, P.J., van der Kuip, D., de Ridder, M.A.J., Witteman, J.C.M., Breteler, M.M.B., Van Broeckhoven, C., & can Duijn, C.M. (2004). The impact of APOE on myocardial infarction, stroke, and dementia. Neurology, 62, 1196-1198.
33. Small, G.W., Mazziotta, J.C., Collins, M.T., Baxter, L.R., Phelps, M.E., & Mandelkern, M.A. et al. (1995). Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for Alzheimer disease. JAMA, 273, 942-947.
34. Smith, G.E., Bohac, D.L., Waring, S.C., Kokmen, E., Tangalos, E.G., Ivnik, R.J., & Petersen, R.C. (1998). Apolipoprotein E genotype influences cognitive "phenotype" in patients with Alzheimer's disease but not in healthy control subjects. Journal of Neurology, 50, 355-362.
35. Spieler, D.H., Balota, D.A., & Faust, M.E. (1996). Stroop performance in healthy younger and older adults in individuals with dementia of the Alzheimer's type. Journal of Experimental Psychology: Human Perception and Performance, 22, 461-419.
36. Stroop, J. (1935). Studies of interference in serial verbal reactions. Journal of Experimental Psychology, 18, 643-661.
37. van Dijk, E.J., Prins, N.D., Vermeer, S.E., Hofman, A., van Duijn, C.M., Koudstaal, P.J., & Breteler, M.M. (2004). Annals of Neurology, 55, 570-575.
38. Van Hoesen, G.W. & Solodkin, A. (1993). Some modular features of temporal cortex in humans as revealed by pathological changes in Alzheimer's disease. Cerebral Cortex, 3, 465-475.
39. Wetter, S.R., Delis, D.C., Houston, W.S., Jacobson, M.W., Lansing, A., Cobell, K., Salmon, P., & Bondi, M.W. (submitted). Heterogeneity in verbal memory: A marker of preclinical Alzheimer's disease?. Neuropsychology.